Prosecution Insights
Last updated: April 19, 2026

Gw Research Limited

6 pending office actions

Portfolio Summary

6
Total Pending OAs
0
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18005961 USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES TOWNSLEY, SARA ELIZABETH 1629 Non-Final OA Aug 30, 2023
18005960 USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES TOWNSLEY, SARA ELIZABETH 1629 Non-Final OA Aug 28, 2023
18005851 CANNABIDIOL FOR USE IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES IVANOVA, SVETLANA M 1627 Non-Final OA Jan 18, 2023
18005959 USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES JAVANMARD, SAHAR 1622 Non-Final OA Jan 18, 2023
18005847 USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES ELENISTE, PIERRE PAUL 1622 Non-Final OA Jan 17, 2023
16935005 USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY BAEK, BONG-SOOK 1611 Non-Final OA Jul 21, 2020

Managing Gw Research Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month